FDA Panel Considers Ban on Electric Stimulation Devices for Aversion Therapy

 – April 24, 2014  –– 

Today the FDA Neurological Devices Panel convened to consider a ban on electric stimulation devices for aversive conditioning in patients inflicting self-harm and displaying aggressive behavior. Though the panel made no decision today, it stated that its primary concern is the safety and wellbeing of patients receiving this therapy and recognized the need for clinical trials to examine the benefits and risks of electric stimulation devices in these patients. Panel member Wayne Goodman, MD, Professor and Chair of the Department of Psychiatry, and Professor of Neuroscience at the Icahn School of Medicine at Mount Sinai, said that though many patients have seen benefits from this treatment he is “not ready to say we should disseminate this treatment to others.”


-Dr. Wayne Goodman, Professor, Chair, Psychiatry, Professor, Neuroscience, Icahn School of Medicine at Mount Sinai

Learn more